(Q52028502)

20 April 2018

title

Pharmacological characterization of a novel AVP(4-9) binding site in rat hippocampus. (English)

1 reference

20 April 2018

author name string

Nakayama Y

1

1 reference

20 April 2018

Takano Y

2

1 reference

20 April 2018

Shimohigashi Y

3

1 reference

20 April 2018

Tanabe S

4

1 reference

20 April 2018

Fujita T

5

1 reference

20 April 2018

Kamiya H

6

1 reference

20 April 2018

Tsujimoto G

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

20 April 2018

published in

Brain Research

1 reference

20 April 2018

volume

858

1 reference

20 April 2018

issue

2

1 reference

20 April 2018

page(s)

416-423

1 reference

20 April 2018

Hippocampal lesions block behavioral effects of central but not of peripheral pre-test injection of arginine vasopressin in an appetitive learning task

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

[3H]vasopressin binding to rat hippocampal synaptic plasma membrane. Kinetic and pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Arginine-vasopressin binding sites in rat brain: A quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Effects of vasopressin on active and passive avoidance behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin metabolite, AVP4-9, binding sites in brain: distribution distinct from that of parent peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin neuromodulation in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin metabolite peptide (AVP-(4-9)) binding sites in rat kidney: distribution distinct from vasopressin binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin and oxytocin: distribution and putative functions in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Post-receptor mechanisms underlying striatal long-term depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4-9, in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Role of calcium channel subtypes in calcium transients in hippocampal CA3 neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin(4-9) fragment activates V1a-type vasopressin receptor in rat supraoptic neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Convulsive and hypothermic effects of vasopressin in the brain of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Multiple voltage-dependent mechanisms potentiate calcium channel activity in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Modulation of the arterial baroreceptor reflex by the vasopressin receptor in the area postrema of the hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

CENTRAL EFFECTS OF ARGININE VASOPRESSIN ON BLOOD PRESSURE IN RATS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

The effects of ACTH- and vasopressin- analogues on CO2-induced retrograde amnesia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Discriminative affinity labelling of opioid receptors by enkephalin and morphiceptin analogues containing 3-nitro-2-pyridinesulphenyl-activated thiol residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Neurohypophyseal principles and memory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

Improvement of memory by a vasopressin fragment: importance of individual differences in mnemonic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2901955-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(00)01955-7

1 reference

20 April 2018

1 reference

20 April 2018